Printer Friendly
The Free Library
7,774,290 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Not to your health: new mechanism proposed for alcohol-related tumors.


A glass of wine may be good for the heart--but may promote some cancers. Scientists have now figured out what's behind that sobering observation. New findings suggest that alcohol encourages blood vessels Blood vessels

Tubular channels for blood transport, of which there are three principal types: arteries, capillaries, and veins. Only the larger arteries and veins in the body bear distinct names.
 to infiltrate and nourish nascent tumors.

Researchers have long known that drinking alcohol is a risk factor for stomach, liver, and breast cancers, among others. Previous studies prompted a host of theories--for example, that heavy drinking displaces other nutrients in the diet or that acetaldehyde acetaldehyde (ăs'ĭtăl`dəhīd) or ethanal (ĕth`ənăl'), CH3CHO, colorless liquid aldehyde, sometimes simply called aldehyde. It melts at −123°C;, boils at 20. , a metabolite metabolite, organic compound that is a starting material in, an intermediate in, or an end product of metabolism. Starting materials are substances, usually small and of simple structure, absorbed by the organism as food.  of alcohol, acts as a carcinogen--but they haven't clarified the alcohol-cancer connection.

Seeking an explanation, Jian-Wei Gu and his colleagues at the University of Mississippi Medical Center University of Mississippi Medical Center (UMC) is the health sciences campus of the University of Mississippi (Ole Miss). Located in Jackson, Mississippi (USA), it houses the Schools of Medicine, Dentistry, Nursing, Health Related Professions, and Graduate Studies in the Health  in Jackson inoculated chick embryos with human fibrosarcoma fibrosarcoma /fi·bro·sar·co·ma/ (-sahr-ko´mah) a malignant, locally invasive, hematogenously spreading tumor derived from collagen-producing fibroblasts that are otherwise undifferentiated.  cells, derived from a type of bone cancer. Since chick embryos support human-cell growth and can be monitored through a window cut into their shells, they are frequently used for studying cancers that grow in people.

Gu's group dosed some of the embryos for 9 days with an amount of alcohol corresponding to about two glasses of wine a day in people. Other embryos received a saline solution instead. They were all then observed for 17 days.

In the embryos given saline, only a few new blood vessels infiltrated the tumors, which grew only slightly. However, tumors in the alcohol-treated embryos developed an extensive network of blood vessels, a process called angiogenesis angiogenesis /an·gio·gen·e·sis/ (-jen´e-sis) vasculogenesis; development of blood vessels either in the embryo or in the form of neovascularization or revascularization.

an·gi·o·gen·e·sis
n.
, and doubled in size.

Further examination showed that cancer cells in the alcohol-dosed embryos, unlike their saline-only counterparts, secreted a protein called vascular endothelial growth factor Vascular endothelial growth factor (VEGF) is an important signaling protein involved in both vasculogenesis (the de novo formation of the embryonic circulatory system) and angiogenesis (the growth of blood vessels from pre-existing vasculature). . This protein, Gu's team notes in the Jan. 15 Cancer, probably signaled blood vessels to grow into the embryos' tumors.

Gu says that a similar mechanism might encourage the growth of tumors that spontaneously arise in people. The immune system regularly kills off small tumors before they acquire blood vessels. "Without blood vessels, cancer can't grow very fast" he says. "If something [such as alcohol] promotes tumor angiogenesis, it's a very important mechanism for cancer growth."

Judah Folkman, a cancer researcher at Harvard Medical School Harvard Medical School (HMS) is one of the graduate schools of Harvard University. It is a prestigious American medical school located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts.  in Boston, says that Gu's hypothesis "sounds logical" but must be tested in people. If it proves correct, the finding may put a damper on current recommendations to have a daily drink to promote heart health (SN: 3/8/03, p. 155). "The question is, At what level would it be counterproductive for people who are at risk for cancer?" says Folkman.

For now, Gu proposes a prudent approach to drinking: "If you're healthy and of legal age, drinking a little bit is fine. But we believe if a person has a high risk of cancer, they shouldn't drink."
COPYRIGHT 2005 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:This Week
Author:Brownlee, C.
Publication:Science News
Geographic Code:1USA
Date:Jan 15, 2005
Words:436
Previous Article:Hands-on math insights: teachers' mismatched gestures boost learning.(This Week)
Next Article:Living in a fog: secondhand smoke may dull kids' wits.(This Week)
Topics:



Related Articles
Why and wherefores of drug resistance. (cancer cell research)
Human gene-splice test considered.
Anticancer drugs: in vivo la difference! (drug resistance)
Reduced incidence of drunk driving deaths encourages tougher laws.
Aging cells may promote tumors nearby.(cancer research)(Brief Article)
Setting a stage for cancer: another reason for women not to drink while pregnant.(This Week)
Quick-trials for novel cancer therapies: exploratory grants.(Fellowships, Grants & Awards)
Alcohol spurs cancer growth.(BIOCHEMISTRY)(Brief article)
A survival-adjusted quantal-response test for analysis of tumor incidence rates in animal carcinogenicity studies.(Research)
Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesis.(Mini-Monograph)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles